Cellectar Biosciences, Inc.

We are excited to share our Phase 1 dose finding study evaluating the safety, tolerability, and efficacy of iopofosine I 131 in children, adolescents, and young adults with inoperable relapsed and refractory high-grade glioma trial in progress poster at Society of Neuro-Oncology. We extend our heartfelt gratitude to the patients, families, caregivers, and investigators for their invaluable participation in this trial. A special thank you to the Society of Neuro-Oncology, with an extra note of appreciation to Dr. Sameer Farouk Sait for serving as the presenting author. #SNO, #oncology, #AYA, #neurooncology, #PediatricHighGradeGlioma, #kidsfightingcancer, #pediatriccancerawareness at www.pediatrichggtrial.com

Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225 https://bit.ly/4ftGAy4

Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer https://bit.ly/3Z1hBfJ

Today, around the U.S., we pause to honor the service and sacrifice of our veterans. At Cellectar Biosciences, we are grateful for those who have bravely served our country and are proud to support our nation's heroes.💙❤️ #VeteransDay #SupportOurVeterans #Community

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024 https://bit.ly/3O42gow #ConferenceCall #Cellectar

We are thrilled to announce that Cellectar has been selected to present new data from the Phase 2 CLOVER-WaM study in an oral session at #ASH24. Learn more: https://bit.ly/ASH2024CLRB

If your child has been diagnosed with High-Grade Glioma, ask your doctor about our #HGG clinical trial. Learn more about it at www.pediatrichggtrial.com. Thank you to Pediatric Cancer Research Foundation for this very informative infographic. #pediatriccancer #PediatricBrainCancer #defeatDIPG #ChildhoodCancer

Do you or someone you love have #HighGradeGlioma? Please consider our pediatric #ClinicalTrial exploring a potential new treatment for kids #pediatriccancerawareness🎗 at www.pediatrichggtrial.com. Check out Team Jack Foundation for more information about childhood brain cancer. #endbraintumors #pediatriccancer #CancelChildhoodCancer #pediatricbraintumor #curethekids💪💪💪🎗️🎗️🎗️ #kidsfightingcancer💛

We are proud to have participated in the International Workshop on Waldenstrom's Macroglobulinemia (IWWM) this week in Prague. Advancing understanding of this rare and complex disease is critical for patients and healthcare providers alike. By bringing together researchers, clinicians, and patient advocates, the WM community can move closer to advances in patient care. #IWWM2024 #CancerResearch #RareDiseases #WMCommunity #HealthcareInnovation #PragueConference

We were excited to be at the International Workshop on Waldenstrom's Macroglobulinemia (IWWM) in Prague this week, where the global medical community came together to share and discuss cutting-edge research on WM, a rare form of non-Hodgkin lymphoma. We are proud to be a Gold Sponsor for this important meeting. This workshop represents a significant step in the fight against Waldenstrom's, and it’s inspiring to see the collaboration and progress being made in this rare disease. #IWWM2024 #CancerResearch #HealthcareInnovation #LymphomaAwareness #PragueConference #WMResearch